These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26982493)

  • 1. Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.
    Seger C; Shipkova M; Christians U; Billaud EM; Wang P; Holt DW; Brunet M; Kunicki PK; Pawiński T; Langman LJ; Marquet P; Oellerich M; Wieland E; Wallemacq P
    Ther Drug Monit; 2016 Apr; 38(2):170-89. PubMed ID: 26982493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
    Shipkova M; Hesselink DA; Holt DW; Billaud EM; van Gelder T; Kunicki PK; Brunet M; Budde K; Barten MJ; De Simone P; Wieland E; López OM; Masuda S; Seger C; Picard N; Oellerich M; Langman LJ; Wallemacq P; Morris RG; Thompson C; Marquet P
    Ther Drug Monit; 2016 Apr; 38(2):143-69. PubMed ID: 26982492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices.
    Seyfinejad B; Jouyban A
    J Pharm Biomed Anal; 2021 Oct; 205():114315. PubMed ID: 34399192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current opinions on therapeutic drug monitoring of immunosuppressive drugs.
    Shaw LM; Holt DW; Keown P; Venkataramanan R; Yatscoff RW
    Clin Ther; 1999 Oct; 21(10):1632-52; discussion 1631. PubMed ID: 10566561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunity to monitor immunosuppressive drugs in peripheral blood mononuclear cells: where are we and where are we going?
    Lemaitre F; Antignac M; Verdier MC; Bellissant E; Fernandez C
    Pharmacol Res; 2013 Aug; 74():109-12. PubMed ID: 23792083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs.
    Christians U; Vinks AA; Langman LJ; Clarke W; Wallemacq P; van Gelder T; Renjen V; Marquet P; Meyer EJ
    Ther Drug Monit; 2015 Dec; 37(6):718-24. PubMed ID: 26291980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic Drug Monitoring of Immunosuppressive Drugs].
    Satoh S; Miura M
    Rinsho Byori; 2016 Dec; 64(12):1381-1389. PubMed ID: 30653902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus: has it gained from experience with older drugs?
    Holt DW
    Therapie; 2002; 57(2):128-32. PubMed ID: 12185960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic principles of immunosuppressive drugs.
    Budde K; Glander P
    Ann Transplant; 2008; 13(3):5-10. PubMed ID: 18806727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome.
    Kuypers DR
    Transpl Int; 2005 Feb; 18(2):140-50. PubMed ID: 15691265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic monitoring and outcomes of cyclosporine.
    Pollard SG
    Transplant Proc; 2004 Mar; 36(2 Suppl):404S-407S. PubMed ID: 15041375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
    Kuypers DR; Le Meur Y; Cantarovich M; Tredger MJ; Tett SE; Cattaneo D; Tönshoff B; Holt DW; Chapman J; Gelder Tv;
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):341-58. PubMed ID: 20056756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry-based pharmacodynamic monitoring after organ transplantation.
    Dieterlen MT; Eberhardt K; Tarnok A; Bittner HB; Barten MJ
    Methods Cell Biol; 2011; 103():267-84. PubMed ID: 21722807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of immunosuppressant drugs].
    Rentsch KM
    Ther Umsch; 2008 Sep; 65(9):545-50. PubMed ID: 18791969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.